InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,522.30
(
1.58%
)
US TECH 100
19,012.00
(
3.88%
)
Dow Jones
40,842.79
(
0.24%
)
Brent Oil
81.51
(
-0.01%
)
Bitcoin
64,199.29
(
-0.62%
)

Replies to post #9905 on Cannabis Science Inc (fka CBIS)

Replies to #9905 on Cannabis Science Inc (fka CBIS)
icon url

newmedman

10/23/10 4:01 PM

#9907 RE: SurgeGuy2.0 #9905

Yeah what he said....Ride the lightning....
icon url

TA_Sleuth

10/23/10 4:05 PM

#9909 RE: SurgeGuy2.0 #9905

Please explain the Divvy.
icon url

boodlebing

10/23/10 4:45 PM

#9917 RE: SurgeGuy2.0 #9905

What price are you planning on selling 50% of your holdings on? thanks!
icon url

happyrobot42

10/23/10 5:16 PM

#9921 RE: SurgeGuy2.0 #9905

sums it up well, nice post
icon url

fink

10/23/10 5:29 PM

#9923 RE: SurgeGuy2.0 #9905

You posted " the company still needs to raise money to fund the FDA process"

That was covered Sept 20th pr

September 20, 2010

COLORADO SPRINGS, CO--(Marketwire - September 20, 2010) - Cannabis Science Inc. (OTCBB: CBIS) ("Cannabis Science, CBIS, or Company"), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce that its Board of Directors have begun investigating the corporate and legal requirements required to issue dividends to shareholders to create a new class of common shares. The company is in advanced negotiations with several groups pursuing funding opportunities for up to $5 million between $1.00 and $3.00 per new share. The proceeds will be used to fund FDA clinical trials, acquisitions, and further product research and development.